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MICROVASCULAR 
COMPLICATIONS IN SOUTH 
AFRICAN PATIENTS WITH LONG-
DURATION DIABETES MELLITUS 
Ayesha A Motala, Fraser J Pirie, Eleanor Gouws, 
Aslam Amod, Mahomed A KOmar 
Objective. To determine the prevalence of microvascular 
complications in South African black and Indian patients 
with long-duration diabetes mellitus (DM). 
Design. A retrospective analysis was undertaken of clinical 
records of 219 DM patients (132 black, 87 Indian) with long-
duration DM (over 10 years) attending a diabetes clinic in 
Durban. Data recorded on each subject included 
demographic details (age, gender, ethnic group, type of 
diabetes, age of onset and duration of diabetes), presence of 
retinopathy, markers of nephropathy and biochemical 
variables. The prevalence of complications and the clinical 
and biochemical parameters were evaluated for type 1 and 
type 2 diabetes and for each ethnic group. 
Results. Of the 219 patients, 47 had type 1 DM (36 blacks, 11 
Indians) and 172 were classilied a type 2 DM (96 blacks, 76 
Indians). The mean age of onset of DM wa later in blacks 
than Indians, both for type 1 (P < 0.05) and type 2 DM (P < 
0.01). In patient with type 1 DM, the prevalence of 
retinopathy was 53.2% (blacks 55.6%, lndians 45.5%}, 
persistent proteinuria was found in 23.4% (blacks 25%, 
Indians 1 .2%) and hypertension in 34%. o ethnic difference 
was found except for the prevalence of hypertension which 
was higher in blacks than Indians (41.7% v. 9.1%, P < 0.5). 
Onset of retinopathy from time of diabetes diagno i 
occurred earlier in blacks than Indians (13.0 ± 4.6 yr v. 18.0 ± 
4.6 yrs, P < 0.05). For the type 2 DM group, r tinopathy was 
found in 64.5% (black v. Indian 68.8 v. 59.2%) and per istent 
proteinuria in 25% (black v. Indian 30.2 v. 1 .4%). 
Hyperten ion was observed in 68% and wa more prevalent 
in blacks (84.4 v. 47.4%, P < 0.01} There was an earlier onset 
of retinopathy (P < 0.05) and hypertension (P < 0.01) from 
time of diabetes diagno is in blacks than Indians. In the type 
1 DM group retinopathy was associated with a ignificantly 
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longer duration of diabetes (P < 0.05) and higher glycated 
haemoglobin (HbA1) (P < 0.05). For type 2 DM subjects there 
was a significant association between retinopathy and longer 
duration of diabetes (P < 0.05) and higher systolic blood 
pressure (P < 0.05). 
Conclusion. This study has shovm that there is a high 
prevalence of microvascular complications in South African 
patients with long-duration diabetes mellitus. 
5 Afr Med / 2001; 91: 987-992. 
Traditionally diabetes mellitus (DM) has been regarded as a 
disease of urbanisation and industrialisation, and one that is 
still rare or unknown in rural Africa.U But, based on World 
Health Organisation (WHO) criteria and age-standardised 
estimates, !Gng and Rewers' have shown that diabetes in adults 
is a global problem and that populations in developing 
countries, minority groups and disadvantaged communities in 
industrialised countries face the greatest risk. Data on diabetes 
epidemiology in Africa have shown that although the 
prevalence is low in some rural communities, in other countries 
there is a moderate prevalence comparable with that found in 
developed countries.3 
It is well established that there is increased morbidity and 
mortality associated with diabetes complications, both 
microvascular and macrovascular. The natural history and 
clinical course of diabetes in Africa is poorly understood, in 
many instances because of poor follow-up.' Earlier reports have 
indicated that unlike in Western populations where the major 
causes of mortality were cardiovascular and renal disease, in 
Africa the major aetiological factors were acute metabolic and 
infective.'·.,; More recently, reports from Ethiopia7 and South 
Africa• have indicated a changing pattern, with diabetic 
nephropathy playing a more important role in mortality. 
In Western countries the prevalence of retinopathy ranges 
from 2% to 90% and that of nephropathy from 2% to 20% 
depending on type and duration of diabetes.• Reports on 
prevalence of macrovascular complications in Africa are 
limited. Previous impressions that microvascular complications 
are rare in Africa were probably related to shorter survival 
rates and inadequate screening.' Earlier studies (before 1990) 
from Africa have reported that the prevalence of retinopathy 
was 2.9 - 57.1% and that of nephropathy 1.0- 30.5%;' however, 
such studies involved mixed cohorts of type 1 and type 2 
diabetes patients with varying duration of disease. 
Although several studies have examined subjects with 
diabetes duration of 10 years or more, only three reports on 
well-defined groups have examined diabetes outcome! .s.w Such 
studies showed that in type 1 diabetes7"' retinopathy was found 
in 40 - 50% and nephropathy in 20 - 28%. In Ethiopian type 2 
patients with DM duration over 20 years, retinopathy was 
ovember 2001, Vol. 91, o. 11 SAMJ 
found in 45.5% and nephropathy in 29.8% of cases.10 
In a recent report11 of an audit of primary health care servi es 
in Cape Town, a high prevalence of complications was fount ; 
however, again this report included both type 1 and type 2 
diabetes patients and with varying duration of disease. 
This retrospective analysis was undertaken to determine t e 
prevalence of retinopathy and nephropathy in South African 
blacks and Indian patients with diabetes duration of over 10 
years. 
pATIENTS AND METHODS 
Patients and background 
The study population comprised South African black and 
Indian patients with diabetes duration over 10 years regis tel ·d 
at the diabetes clinic at !Gng Edward VIII Hospital (KEH), 
Durban. KEH is the major referral hospital not only for the c ty 
but also for the province of KwaZulu-Natal which represent a 
quarter of the total population of the country. 
Patients are reviewed at the diabetes clinic at monthly, 3-
monthly or 4-monthly intervals. At each visit symptomatic 
details are recorded. Clinical examination includes 
measurement of weight, blood pressure (BP) and pulse rate; 
dipstix urine is exaritined for glucose, protein and ketones; 
capillary blood glucose is measured with reflectance meter < 1d 
venous blood samples are taken for estimation of glycated 
haemoglobin, plasma glucose, serum fructosarnine, serum 
lipids, urea and electrolytes. Annually, fundal examination, 
visual acuity and glomerular filtration rate (GFR) are assess• J 
Records of such information are available from 1983. 
Methods 
Using ovember 1995 as the reference end-point of the stu .', 
information was obtained on demographic data, presence or 
absence of retinopathy and markers of nephropathy and 
biochemical variables. Demographic details included the 
following: age, gender, ethnic group, type of diabetes, age ot 
onset and duration of diabetes and the date of the last clinic 
visit if the subject was lost to follow-up. 
The information recorded regarding retinopathy included 
presence or absence of retinopathy; if present, whether it was 
background or proliferative; use of laser treatment and 
estimation of duration from time of diabetes diagnosis to the 
onset of retinopathy. 
The markers of diabetic nephropathy evaluated included 
persistent dipstix proteinuria, hyperter\Sion, serum creatinine 
and GFR. The pres~nce ·or absence of proteinuria over the 
previous six visits (18 months) was recorded. The mearlS of 
three values per year for systolic and diastolic BP were 
calculated. A record was kept of hypertension requiring 
treatment from the time of diabetes diagnosis. Hypertension 
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1\ s defined using WHO criteria,'2 i.e. systolic BP ~ 160 mmHg 
or diastolic BP ~ mmHg or if the patient was receiving 
aJ ihypertensive treatment; borderline hypertension was 
dt ·ined as BP > 140/90 mmHg but< 160/95 mmHg. The most 
r~ ent serum creatinine and GFR measurements and their 
dt ,ation from time of diabetes onset were noted. 
"he means of three values per year were calculated for finger 
pr ck capillary glucose, venous plasma glucose, HbA1 (before 
JC 3) and HbA1c (after 1993). Retinopathy was evaluated by the 
re Jrd of findings at annual fundal examination done through 
d1 tted pupils using hand-held monocular direct 
o; tthalmoscopy. Retinopathy was classified as background, 
p· -proliferative or proliferative.U 
rsistent proteinuria was defined as dipstix proteinuria on 
tl- 'e or more consecutive occasions over 18 months in the 
a( nee of infection or cardiac failure, serum creatinine was 
dt ned as abnormal if the value was> 115 ~ol/1 at the last 
vr t, and abnormal GFR was defined if GFR < 95 rnl/min in 
" nen and GFR < 98 rnl/ min in men. 
B. chemical tests 
Tl methods used for the biochemical variables were as 
fo 1ws: venous plasma glucose was measured using a glucose 
m lase method; cation exchange rnicrocolumn 
cl- 1matography for HbA1 (normal range 5 - 8%); enzyme-
lu· ed immunosorbent assay (ELISA) technique for HbA1c 
(n mal range 3.5- 5.6%); serum creatinine was measured by 
re tion rate (normal range 53 - 115 ~ol/1). GFR was assessed 
ll> •g ""'Tc- DTPA (normal range 98- 150 rnl/ min for men, 95 -
12 ml/ min for women). · 
Statistical an alysis 
Statistical analysis was performed using the SAS computer 
programme." The prevalence of complications and the clirlical 
and biochemical parameters were evaluated for type 1 and 
type 2 diabetes and for each ethnic group. Data are expressed 
as means ± standard deviations (SD) or prevalence (%). Ethnic 
differences were assessed using the unpaired Student's t-test 
for numerical data and the chi-square test for categorial data. A 
P-value < 0.05 was regarded as significant. 
R ESULTS 
The study group comprised 219 patient (159 women, 60 men; 
132 blacks, 87 Indians) identified as having had diabetes for 
over 10 years and who constituted 25.2% of the 870 patient 
registered at the diabete clinic. Of these, 172 subject (7 .5%) 
had type 2 diabetes and 47 (21.5%) had type 1 diabetes. 
Clinical characteristics 
Table I shows the clinical and biochemical characteristic . In 
both the type 1 and type 2 diabetes groups the mean age of 
onset was later in black than Indian patients (P = 0.03, type 1; 
P = 0.004, type 2), and BP wa higher (P < 0.05). While BP 
control appeared reasonable, overall g lycaemic control, as 
judged by glycated haemoglobin level, wa uboptimal in both 
ethnic group . 
Prevalence of complications (Table IJ) 
In the type 1 diab tes group retinopathy wa found in over half 
of the patients; the mean on et of retinopathy from time of 
1 leI. Clinical and biochemical characteristics of 219 ~ubjects with long-duration diabetes memtus (DM) (> 10 yYS)• 
Type 1 diabetes Type 2 diabetes 
\olfiable Total Black Indian P-value Total Black Indian P-value 
l\ .unber 47 36 11 172 96 76 
Cender (F /M) (N) 28:19 22:14 6:5 131:41 72:24 59:7 
Age (yrs) 39.5 ± 10.9 39.9 ± 11.2 38.0 ± 10.5 0.6 58.4 ± 9.4 59.1 ± 7.8 57.4 ± 11 .0 0.3 
Age of onset (yrs) 22.5 ± 11.0 24.3 ± 11.4 16.6 ± 7.4 0.03 39.9 ± 9.4 41. ± 8.0 37.5 ± 10.5 0.004 
Duration (yrs) 16.10 ± 4.9 15.6 ± 3.6 21.3 ± 6.8 0.005 1 .6 ± 5.7 17.4 ± 4.9 20.2 ± 6.2 0.002 
L t to follow-up (N (%)) 16 (34) 9 (25) 7 (63.6) 0.07 57 (33.1) 
32 (33.3) 25 (32.9) 0.1 
BlOOd pressure (mmHg) 
Systolic 133 ± 13.6 135.3 ±u.s 125.9 ± 15.4 0.04 144.7 ± 13.3 147.2 ± 12. 141.4 ± 13.5 0.0052 
Diastolic 82.1 ± 8.1 83.5 ± 7.8 77.7 ± 2. 0.03 84.4 ± 
.4 86.7 ± .2 1.4 ± 7.9 0.0001 
Plasma glucose (mmol/1) 10.8 ±4.2 11.5 ± 4.1 .2±3.5 0.02 12.1 ± 3.9 12.1 ± 4.7 12.1 ± 3.4 0.0195 
HbA1 (%)1: 9.5 ± 1.5 9.9 ± 1.5 9.5 ± 1.4 
0.5 9.7 ± 1. 10.0 ± 2.1 9.3 ± 1.4 0.02 
HbAlc (%)§ 9.8 ± 2.2 10.2 ± 2.3 8.6 ± 1.6 0. 
9. ± 2.1 9. ±2.2 9. ± 2.1 0.1 
Serum creatinine (p.mol/1) 99.2 ± 77.1 95.7 ± 68.5 111.5 ± 105.2 0.6 132.4 ± 174.5 147.2 ± 212.7 113.6 ± 106.2 02 
Glomerular filtration rate 
(ml/min) 98.6 ±33.9 9 .5 ± 31.5 99.1 ± 429 0.9 
77.0 ± 32.9 74.6 ± 32.1 80.1 ±34.1 0.2 
·o 
p~ta are means ±SO, except as noted. 
t N ~ue: Black v. Indian. 
§ N = 43, type I; N = 149, type 2. 
-30, type 1; N = 123, type 2. 
Table II. Prevalence of microvascular complications in 219 patients with diabetes mellitus (D M), duration > 10 yrs (% (N)) 
Type 1 DM 
(% (N)) 
Total Black Indian 
(N= 47) (N =36) (N = 11) 
Retinopathy 
Any 53.2 (25) 55.6 (20) 45.5 (5) 
Background only 38.3 (18) 38.9 (14) 36.4 (4) 
Proliferative 14.9 (7) 16.7 (6) 9.1 U) 
Laser treatment 17.0 (8) 16.7 (6) . 18.2 (2) 
Onset from DM diagnosis (yrsY 14 ± 4.9 13.0 ± 4.6 18.0 ± 4.6 
Proteinuria 
Persistent (p.p) 23.4 (11) 25.0 (9) 18.2 (2) 
Without retinopathy 0 (0) 0 (0) 0 (0) 
Onset from DM diagnosis (yrs)* 11.4 ± 3.2 10.3 ± 2.1 16.5 ± 2.1 
Hypertension 
9.1 (1)+ Requiring treatment 34.0 (16) 41.7 (15) 
BP ;e: 160/95 mmHg 10.6 (5) 11.1 (4) 9.1 (1) 
BP ;e: 130/85 mmHg 57.5 (27) 66.7 (24) 27.3 (3) 
Onset from DM diagnosis (yrs)* 9.6 ± 3.5 9.3 ± 0.3 14.0 ± 0 
Abnormal serum creatininel 17.8 (8) 17.1 (6) 20.0 (2) 
Glomerular filtration rate (ml/min) 
< 95 (women), < 98 (men) 39.5 (17) 39.4 (13) 40.0 (4) 
<70 20.9 (9) 18.0 (6) 30.0 (3) 
""Mean±SD. 
t P-value: black v. Indian. 
l > 115 pmol/ 1. 
diagnosis was significantly earlier in blacks than Indians (13.0 
± 4.6 yrs v. 18.0 ± 4.6 yrs, P = 0.039). Nephropathy on the basis 
of persistent proteinuria was found in approximately one-
quarter of the subjects, all of whom had retinopathy. One-third 
of the patients had hypertension requiring treatment and the 
prevalence was higher in blacks than Indians (41.7% v. 9.1 %, P 
= 0.046); 17.8% of patients had elevated serum creatinine and 
20.9% had abnormal GFR. 
In the type 2 diabetes group the prevalence of retinopathy 
was 64.5%; the mean onset of retinopathy from time of 
diagnosis was significantly earlier in blacks than Indians (13.1 
± 4.9 yrs v. 16.2 ± 7.0 yrs, P = 0.01. Nephropathy based on 
persistent proteinuria was found in 25% of these patients; 6 
(3.5%) had no retinopathy. Hypertension was observed in 68%, 
with a higher prevalence in blacks than Indians (84.4% v. 
47.4%, P = 0.001); the mean onset from time of diagnosis was 
earlier in blacks than Indians (11.7 ± 6.0 yrs v. 16.3 ± 8.2 yrs, P = 
0.001) An elevated serum creatinine was found in 25.2% and 
abnormal GFR in 42% of type 2 diabetes patients. 
Risk factors and complications (Table ill) 
Analysis of known risk factors for microvascular complications 
showed that in type 1 DM subjects retinopathy was associated 
with significantly longer duration of diabetes 
(P = 0.046) and higher HbA1 (P = 0.028). For the type 2 DM 
group, when compared with subjects without retinopathy, the 
November 2001, Vol. 91, o. 11 SAMJ 
Type2DM 
(%(N)) 
P-value+ Total Black Indian P-value+ 
(N = 172) (N = 96) (N = 76) 
0.6 64.5 (111) 68.8 (66) 59.2 (45) 0.2 
0.6 44.2 (76) 47.9 (46) 39.5 (30) 0.2 
0.5 20.4 (35) 20.8 (20) 19.7 (15) 0.9 
0.9 29.7 (51) 26.0 (25) 34.2 (26) 0.2 
0.039 14.4 ± 6.0 13.1 ± 4.9 16.2 ± 7.0 0.01 
0.6 25.0 (43) 30.2 (29) 18.4 (14) 0.08 
13.9 (6) 10.4 (3) 21.4 (3) 0.06 
0.0045 13.4 ± 4.8 13.5 ± 4.7 13.4 ± 4.9 0.9 
0.046 68.0 (117) 84.4 (81) 47.4 (36) 0.001 
0.9 19.1 (31) 23.9 (22) 12.7 (9) 0.07 
0.021 90.2 (148) 92.5 (86) 87.3 (62) 0.001 
0.2 13.1 ± 7.1 11.7 ± 6.0 16.3 ± 8.2 0.001 
0.8 25.2 (43) 29.2 (28) 20.0 (15) 0.2 
0.9 73.4 (124) 73.4 (69) 73.3 (55) 0.9 
0.4 42.0 (71) 46.8 (44) 36.0 (27) 0.2 
duration of diabetes was longer (P = 0.04) and systolic BP 
higher (P = 0.0125) in subjects with retinopathy. 
D ISCUSSIO N 
This study of South African black and Indian patients with 
long-duration(> 10 years) type 1 and type 2 DM shows an 
increased prevalence of retinopathy and nephropathy. Ethni-
comparisons demonstrate that the prevalence of hypertensicn 
was higher and the onset of retinopathy earlier in blacks tha 1 
Indians. 
It is difficult to compare the results of this study with othH 
studies from Africa since most studies have examined mixed 
cohorts of type 1 and type 2 diabetes patients, with varying 
duration of disease.1 
For type 1 diabetes comparison is only possible with two 
outcome studies from Africa.'.a When compared with the recent 
South African report of 36 patients with mean diabetes 
duration of 13 years, the prevalence of retinopathy is similar 
(53.2% v. 52%), persistent proteinuria lower (23.4% v. 28%) and 
hypertension higher (34% v. 22%). In Ethiopian subjects, 
Lester' reported prevalence rates of 40.7% for retinopathy and 
20% for persistent proteinuria and hypertension respectively in 
a cohort of patients with diabetes duration of over 10 years. 
The apparent low prevalence rates in other African studies is 
probably accounted for by the varying diabetes durations of 
1 ORIGINAl ARTICLES 
fable Ill. Relationship between microvascular complications and known risk factors in 219 patients with long-duration diabetes mellitus (DM) 
Type 1OM (N = ~7) Type 2OM (N = 172) 
Retinopathy Persistent proteinuria Retinopathy Persistent proteinuria 
lisk factor Yes No Yes 
llood pressure (mmHg) 
Systolic 133.6 ± 13.9 132.5 ± 13.7 140.8 ± 17.1 
Diastolic 80.7 ±7.5 83.7 ± 8.7 85.6 ± 8.2 
-:apillary glucose (mM) 10.8 ±2.4 10.2 ± 3.2 10.5 ± 2.3 
'lasma glucose (mM) 11.7 ±4.3' 9.8 ±3.9 10.7 ± 3.3 
lliAI (%) 10.2 ± 1.7 9.2 ± o.8t 10.3 ± 2.3 
Ale(%) 10.1 ±2.3 9.5 ± 2.2 10.2 ± 2.8 
.ge of onset (yrs) 23.6 ± 10.8 21.2 ± 11.5 23.2 ± 10.4 
liabetes duration (yrs) 18.3 ±5.2 15.4 ± 4.3t 17.4 ± 6.3 
ta are means ± SD. 
P < 0.05: yes v. no. 
P : 0.052: yes v. no. 
tl subjects studied and possibly shortened survival rates.' The 
o ,erved prevalence of retinopathy and persistent proteinuria 
iJ his study is compatible with reports from the Western 
li rature!·"·'s 
t is interesting that although no ethnic difference was 
o~ .erved for the prevalence of retinopathy and persistent 
P •teinuria, hypertension was more prevalent in blacks than 
h 'ians. This finding is in contrast with earlier reports on 
P· ients with shorter duration type 1 diabetes which showed 
n ethnic difference,'• but it is compatible with other reports 
1' ich highlight the high prevalence of hypertension in black 
A ·icans• and with epidemiological evidence indicating that in 
St tth Africa hypertension is more prevalent in blacks (25%) 
th n Indians (14%)." 
1h e finding of later onset of diabetes in blacks than Indians 
is ompatible with previous South African studies in which 
or .et was found to be later in blacks than Indians•• ... and 
h ropids.•• However, studies from North America found 
similar age of onset in black and white children."' 
' espite the later onset of diabetes, the onset of retinopathy 
from time of diagnosis was earlier in blacks than Indians. The 
reasons for this are unclear since there was no difference in 
glycaemic control between the two groups. It is possible, 
~owever, that the higher prevalence of hypertension in blacks 
1 responsible for the acceleration of retinopathy. 
ln type 2 diabetic subjects the prevalence of retinopathy and 
persistent proteinuria is similar to rates reported in the Western 
literature!·'3·'5 As for type 1 diabetes, comparison with other 
African studies is difficult because of mixed cohorts of type 1 
anct type 2 diabetes and varying diabetes duration in such 
tudies.' otwithstanding, in the Ethiopian report'" on 121 
Predominantly type 2 patients with diabetes of over 20 years' 
duration the prevalence of retinopathy (45.5%) was lower than 
No Yes 0 Yes 0 
130.1 ± 0.9 146.6 ± 12.9 141.3 ± 13.6t 146.9 ± 11.8 143.3 ± 14.0 
80.8 ± 7.8 84.8 ± 7.8 83.7 ± 9.4 85.6 ± 7.8 83.7 ± 8.8 
10.5 ± 2.9 11.7 ± 2.6 11.7 ± 2.5 11.7 ± 2.9 11.7 ± 2.4 
10.8 ± 4.5 12.4 ± 3.5 11.5 ± 4.5 11.9 ± 4.0 12.2 ± 3.8 
9.6 ± 0.9 9.9 ± 2.0 9.4 ± 1.5+ 9.6 ± 1.7 9.8 ± 1.9 
9.7 ± 2.0 9.9 ± 1.9 9.6 ± 2.4 10.2 ± 2.3 9.6 ± 1.9 
22.2 ± 11.4 40.2 ± 9.8 39.5 ± 8.8 39.2 ± 9.0 40.3 ± 9.7 
16.8 ± 4.4 19.2 ± 6.2 17.6 ± 4.3t 19.2 ± 5.1 18.3 ± 5.9 
in this study, while that of persistent proteinuria (29.8%) was 
similar. The lower prevalence of retinopathy (55.4%) and 
persistent proteinuria (5.3%) found in a recent audit of South 
African blacks can be explained by the varying duration of 
diabetes in the patients studied (mean duration 8 years, range 
0- 28 years); moreover, that report included type 1 subjects." 
Ethnic difference was only observed for prevalence of 
hypertension, which was higher in blacks than in Indians and 
might reflect the high background prevalence in blacks.17 
As for type 1 diabetes, the onset of retinopathy from time of 
diagnosis was earlier in blacks than Indians; the difference may 
be accounted for by the higher BP levels in black patients. 
What is also apparent from this analysis is that in the group as 
a whole glycaemic control is poor; this clearly highlights the 
need for more aggressive intensive management to optimise 
control. 
ln conclusion, this study has shown that in South African 
black and Indian patients with long-duration diabetes there is a 
high prevalence of microvascular complications. Previous 
impressions that microvascular complications are rare in Africa 
were probably related to shorter survival rates and inadequate 
screening; as surviva' rates improve and there are greater 
numbers of African patients with long-duration diabetes, the 
pattern will probably be similar to that observed in the Western 
world. 
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AN ASSESSMENT OF GROWTH 
IN HIGH AND LOW SOCIO-
ECONOMIC STATUS 
SCHOOLCHILDREN IN SOUTH 
AFRICA 
G J Louw, S M Naidoo 
'We are guilty. of many errors and many faults, but our 
worst crime is abandoning the children, neglecting the 
foundation of life. Many of the things we need can wait. 
The child cannot .• Right now is the time his bones are beinf 
formed, his blood is being made and his senses are being 
developed. To him we cannot answer "Tomorrow". His 
name is "Today".' 
(Gabriela Mistral, 1948, World Health Organisation, 1997 
The patterns of physical growth (height, weight, length of 
trunk and limbs, circumference of trunk and limbs, and limb 
breadths) and function (grip strength of both hands and 
neuromuscular reaction time) of Cape Coloured (specifically 
mixed origin) schoolchildren from urban and rural areas an 
contrasting socio-economic status (SES) levels, were measurE I. 
The mixed longitudinal study accumulated data over more 
than a decade, and included 929 male and 1 160 female pupi ' 
of high SES (HSES) in the Cape Town urban area, aged 5 - 2C 
years, and 954 male and 1 030 female pupils of low SES (LSE ,) 
in rural areas of the Little Karoo, aged 5- 19 years. Means fo· 
every anthropometric character were calculated and matchec. 
against age for each of the four groups, for comparative 
purposes. Standard deviations were recorded for each 
character. Figs 1 - 16 show the means for each of the 
anthropometric characters, matched with age groups, for HSES 
and LSES boys and girls. 
The results reflect the importance of positive intervention in 
the growth and development of the LSES children at different 
periods for the girls and boys, namely pre-pubertally in girls, 
particularly during the period of possible pre-pubertal growth 
spurt (8 - 10 years of age), and continuously and consistently 
for the boys, from 5 to 19 years and onwards. Intervention 
should take the form of improved diet, increased exercise, and 
plenty of time spent outdoors in the sun. 
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